|Last Price||Today's Change||52-Week Range||Trading Volume|
|29.49||0.28 (+0.96%)||27.76 - 32.96||23.2 million (Above Avg)|
Market data as of 4:00PM 08/27/14. Quotes are delayed by at least 15 min.
Multimedia assets now available: ViiV Healthcare receives FDA approval for Triumeq® (abacavir, dolutegravir and lamivudine), a new single-pill regimen for the treatment of HIV-1 infection
08/25/2014 9:00 AM ET